Skip to main content

Table 3 Methylation frequencies of different genes in the overall series and in non recurrent or recurrent tumors

From: DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach

 

Frequency (%)

Gene

Overall series (n = 74)

Non recurrent tumors (n = 38)

Recurrent tumors (n = 36)

P value*

CD44

1

18

3

0.06

CASP8

1

3

0

1

MLH1 (locus 2)

1

3

0

1

PTEN

3

5

0

0.49

VHL

3

5

0

0.49

BRCA1

4

8

0

0.24

CHFR

4

5

3

1

ATM

5

8

3

0.62

BRCA2

5

8

3

0.62

CDKN1B

5

5

5

1

RARB

6

8

6

1

HIC1

9

16

0

0.03

FHIT

10

1

10

1

MLH1 (locus 1)

11

15

8

0.48

ESR1

12

16

6

0.26

TIMP3

13

18

8

0.31

TP73

14

19

8

0.19

CDKN2A

14

16

14

1

GSTP1

15

26

5

0.02

DAPK

17

24

8

0.11

IGSF4 (CADM1)

21

18

25

0.58

RASSF1 (locus 1)

23

29

14

0.16

APC

29

34

25

0.45

RASSF1 (locus2)

33

45

19

0.03

CDH13

50

53

47

0.81

  1. *Fisher’s exact test 2-tailed P value (difference between recurrent and non recurrent tumors). Significant genes are highlighted as bold data.